This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
This product will be manufactured at Lupin's Pithampur facility in India
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
The estimated national burden of asthma in India is at 17.23 million with an overall prevalence of 2.05% and out of this, approximately 30 lakh patients can be classified under “inadequately controlled”
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
